Intrarosa Insert
Product Images NDC 72495-401

16 FDA label images from Millicent Us, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Intrarosa (NDC 72495-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Millicent Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prasterone (Intrarosa 01)

Prasterone (Intrarosa 01)
Chemical structure diagram of prasterone, the active ingredient in Intrarosa 6.5 mg vaginal inserts. The diagram shows the steroid backbone with hydroxyl and ketone functional groups characteristic of prasterone.*
FDA Label Image

Figure 1 (Intrarosa 02)

Figure 1 (Intrarosa 02)
A three-panel line graph showing plasma levels over 24 hours post-dosing comparing Intrarosa and placebo. Panel A shows Prasterone (ng/ml) levels elevated after Intrarosa dosing compared to placebo. Panel B depicts Testosterone (ng/ml) levels with slight increases post-Intrarosa dosing versus placebo. Panel C illustrates Estradiol (E2) (pg/ml) levels higher after Intrarosa compared to placebo. Error bars indicate variability at each time point.*
FDA Label Image

Step 1 (Intrarosa 03)

Step 1 (Intrarosa 03)
An instructional diagram illustrating the applicator for Intrarosa (prasterone) 6.5 mg vaginal insert. It shows two states of the applicator: non-activated with labeled parts 'Plunger' and 'Open End,' and activated with the plunger extended.*
FDA Label Image

Step 5a (Intrarosa 07)

Step 5a (Intrarosa 07)
Illustration showing the insertion of an Intrarosa 6.5 mg vaginal insert. The image depicts a hand holding the insert applicator, positioned near the vaginal area, demonstrating proper placement technique for the vaginal route.*
FDA Label Image

Step 2 (Intrarosa 04)

Step 2 (Intrarosa 04)
An instructional line drawing showing hands holding a small, rounded vaginal insert, demonstrating the proper way to position the insert between the fingers before use.*
FDA Label Image

Step 5b (Intrarosa 08)

Step 5b (Intrarosa 08)
An instructional diagram depicting the insertion procedure of a vaginal insert, likely representing the use of Intrarosa (prasterone) 6.5 mg. The illustration shows a hand holding the insert, positioned near the vaginal opening with a stylized internal anatomy to demonstrate proper placement.*
FDA Label Image

Step 3 (Intrarosa 05)

Step 3 (Intrarosa 05)
An instructional illustration showing two hands handling a vaginal insert applicator. One hand holds the applicator's barrel while the other hand removes or adjusts the plunger, demonstrating the device's use for inserting the medication.*
FDA Label Image

Step 6 (Intrarosa 09)

Step 6 (Intrarosa 09)
An instructional illustration showing the vaginal insertion of a product, depicting a hand placing an insert into the vaginal canal. The diagram outlines female pelvic anatomy in a simplified style to demonstrate the insertion technique.*
FDA Label Image

Step 4 (Intrarosa 06)

Step 4 (Intrarosa 06)
An instructional line drawing showing a right hand holding a vaginal insert applicator by the base, with the other hand pressing the plunger button, demonstrating how to use the applicator device for vaginal insertion of Intrarosa prasterone vaginal insert 6.5 mg.*
FDA Label Image

Step 7 (Intrarosa 10)

Step 7 (Intrarosa 10)
An instructional diagram shows the insertion of a vaginal insert, illustrating a hand placing the insert into the vaginal canal. The image is likely demonstrating the proper administration technique for the Intrarosa 6.5 mg vaginal insert by Millicent US, Inc.*
FDA Label Image

Cosette Pharmaceuticals (Intrarosa 11)

FDA Label Image

Millicent Pharma (Intrarosa 12)

FDA Label Image

Small Box (Intrarosa 13)

Small Box (Intrarosa 13)
Packaging label for Intrarosa Prasterone Vaginal Inserts, 6.5 mg per insert, containing 28 inserts. The label shows the brand and generic names, dosage form, strength, quantity, and identifies Millicent Pharma as the distributor and Cosette Pharmaceuticals, Inc. as the manufacturer. The design includes pink accents and a rose graphic.*
FDA Label Image

Outer Box (Intrarosa 14)

Outer Box (Intrarosa 14)
Packaging label for Intrarosa Prasterone vaginal inserts, 6.5 mg per insert, containing 28 inserts/applicators. The label shows the product name, strength, dosage form, instructions for use, storage information, and manufacturer details. It is labeled as prescription only and distributed by Millicent U.S. Inc.*
FDA Label Image

Sample Small Box (Intrarosa 15)

Sample Small Box (Intrarosa 15)
Packaging label for Intrarosa vaginal inserts containing prasterone 6.5 mg per insert. The box is predominantly white and pink, marked as a sample not for sale, containing 14 inserts. Manufactured for Cosette Pharmaceuticals and distributed by Millicent US, Inc.*
FDA Label Image

Sample Outer Box (Intrarosa 16)

Sample Outer Box (Intrarosa 16)
Packaging label for Intrarosa 6.5 mg vaginal inserts, containing prasterone. The label indicates a package size of 14 inserts/applicators. It is marked as a sample and not for sale, labeled for prescription use only. Manufactured for Cosette Pharmaceuticals, Inc. and distributed by Millicent U.S., Inc. Storage instructions and dosage details are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.